Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check42 days agoChange DetectedThe website has been updated to version 2.14.2 on January 30, 2025, following the removal of version 2.14.1 on January 7, 2025.SummaryDifference0.7%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has added a new type of intervention in the latest update (v2.14.0) on January 7, 2025, following the removal of the previous type of intervention in version v2.13.3 on December 27, 2024.SummaryDifference2%
- Check78 days agoChange DetectedA new addition was made on December 27, 2024, following the deletion of content on December 16, 2024.SummaryDifference0.3%
Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.